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IRCCS Istituto Clinico Humanitas, Rozzano, ItalyThere have been signiﬁcant advances in our understanding of the
immunobiology of primary biliary cirrhosis (PBC) and, in particu-
lar, a rigorous dissection of not only the serologic abnormalities,
including antimitochondrial autoantibodies (AMA), but also the
deﬁnition of autoreactive CD4+ and CD8+ T cells [1]. Further, there
is increasing evidence for the interplay of genetic and environ-
mental factors in individual host susceptibility. One paradox
has been the selected destruction of small bile ducts in PBC
despite the presence of mitochondrial antigens in virtually all
nucleated cells. This enigma is being addressed with the critical
observation that during apoptosis, biliary epithelial cells (BECs)
translocate immunologically intact PDC-E2 into apoptotic bodies,
constituting an apotope, which is able to induce pro-inﬂamma-
tory cytokine secretion from mature monocyte derived macro-
phages (MDM) from patients with PBC in the presence of AMA,
including high levels of interleukin-12 (IL-12) [2,3]. Importantly,
data from genetic studies of humans with PBC, murine models,
and in vitro experiments have identiﬁed the IL-12 signaling path-
way as a key player in the effector mechanisms that lead to bili-
ary destruction. In fact, genome wide association studies from
three different populations have identiﬁed at least three IL-12
related genes strongly associated to PBC: IL12A, IL12RB2, and
STAT4 [4–6]. In addition, the deletion of IL-12p40 on the trans-
forming growth factor b receptor II dominant negative (dnTGF-
bRII) murine model of PBC has established that the IL-12p40 sub-
unit is essential for the development of autoimmune cholangitis
[7].
IL-12 is a heterodimer comprised of two subunits: a 35-kDa
light chain or p35 (encoded by IL12A gene) and a 40-kDa heavy
chain known as p40 (encoded by IL12B gene), that are secreted
by activated antigen presenting cells (APCs). IL-12 is a major
cytokine for the differentiation of T helper 1 (Th1) cells and plays
an essential pro-inﬂammatory role in both innate and adaptive
immune responses [8]. Two major pathways seem to be involved
in the IL-12 driven Th1 differentiation; ﬁrst, the speciﬁc cellularJournal of Hepatology 20
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Open access under CC BY-NC-ND license.effects of IL-12 are due mainly to its ability to induce activation
of the transcription factor STAT4, which promotes interferon-c
(IFN-c) production, and, together with the triggering of Th1 cell
responses, contributes to loss of tolerance in several models of
autoimmunity [9]. Of note, the p40 subunit is also a component
of the dimeric cytokine IL-23, essential for the differentiation of
Th17 cells. The most important target cells of IL-12 are: T cells,
NK cells, and NKT cells, for which IL-12 induces proliferation, dif-
ferentiation, enhancement of cytotoxicity, and the production of
cytokines, particularly IFN-c; and B cells, for which IL-12, directly
or through the effects of IFN-c, enhances the activation and pro-
duction of Th1-associated classes of immunoglobulin. Further, IL-
12 through STAT4 activation stabilizes t-bet, which itself drives
Th1 differentiation [10]. The IL-12 heterodimer signals through
the cell surface IL-12 receptor, which is composed of two chains,
IL-12Rb1 (encoded by IL12RB1 gene) and IL-12Rb2 (encoded by
IL12RB2 gene). IL-12R is expressed mainly by activated T cells
and NK cells, but has been shown also on other cell types, such
as DCs and B-cell lines.
The above observations allow one to propose a schematic
pathogenesis of PBC (Fig. 1). In apoptosis of biliary epithelial cells,
PDC-E2 remains intact [Fig. 1, step 1] and can provide an autoan-
tigenic stimulus as unmodiﬁed lipoylated PDC-E2, as xenobiotic/
hapten-modiﬁed PDC-E2, or as a microbial mimic of PDC-E2 [step
2]. PDC-E2 is endocytosed by an APC and leads to its maturation
[step 3] and IL-12 secretion [step 4]. If the APC is activated via
stimulation of TLR, self peptides will be presented in immuno-
genic mode via MHC class II to autoreactive CD4+ T cells and
via MHC class I to CD8+ T cells (cross-priming) (not shown).
The IL-12 heterodimer binds then its receptor on the surface of
naïve T cells, NK and NKT cells which leads to Th1 differentiation
[step 5], NK cytotoxicity and ultimately to IFN-c secretion [step
6]. Cytotoxic CD8+ T cells get activated [step 7] which potentiates
the destruction of small apoptotic BECs expressing PDC-E2 [step
8]. INF-c determines also macrophage activation and possibly M1
polarization [2,11]. CD4+ T cells provide help to autoreactive B
cells that produce AMA [step 9]. AMA can form complexes with
PDC-E2 that are phagocyted by APCs via Fc receptors as another
source for antigen presentation [step 10]. Thus, a multilineage
anti-PDC-E2 response is generated. The BEC is vulnerable because
of expression of intact PDC-E2 [see step 1], and expression of
MHC molecules. Intact PDC-E2 released from damaged BEC main-
tains self-perpetuating disease.12 vol. 56 j 731–733
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Fig. 1. Towards common denominators in primary biliary cirrhosis: the role of IL-12. BECs, biliary epithelial cells; AMA, anti-mitochondrial autoantibodies; APC,
antigen presenting cell.
Hepatology SnapshotInterpreting the effects of IL-12 and IFN-c in PBC is compli-
cated, and addressing this issue will require additional studies
that clarify the effector mechanisms involved in the IL-12 and
the related IL-23 signaling pathways. First, based on the lack of
PBC-like disease on the dnTGF-bRII animal model with deletion
of IL-12p40 [7], and the increase secretion of IL-12 from human
macrophages co-cultured with apoptotic BECs [2], we have
herein assumed that IL-12 production is increased in PBC; how-
ever, low levels of IL-12 could also be deleterious if there is loss
of control of Th17 cells; at present, experiments correlating genes
and biologic change have not been done. Second, IL-12 associa-
tions could also be consistent with an infectious etiology, how-
ever, no data linking IL-12 production to damage of a speciﬁc
cell type i.e. BECs in PBC, are available. Third, other important
genes e.g. IRF5, CXCR5, NFKB1 have been shown to be genetically
associated with PBC, although functional data are still missing.
Importantly, high expression of IRF5 is characteristic of M1 mac-
rophages, in which it directly activated transcription of the genes
encoding IL-12 [12]. Finally, the IL-12 pathway highlights the
interplay between innate and acquired immunity, and dissection
of this relationship may provide opportunities for therapeutic
intervention.732 Journal of Hepatology 201Conﬂict of interest
The authors declared that they do not have anything to disclose
regarding funding of conﬂict of interest with respect to this
manuscript.
References
[1] Invernizzi P, Selmi C, Gershwin ME. Update on primary biliary cirrhosis. Dig
Liver Dis 2010;42:401–408.
[2] Lleo A, Bowlus CL, Yang GX, Invernizzi P, Podda M, Van de Water J, et al.
Biliary apotopes and anti-mitochondrial antibodies activate innate immune
responses in primary biliary cirrhosis. Hepatology 2010;52:987–998.
[3] Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR, et al. Apotopes
and the biliary speciﬁcity of primary biliary cirrhosis. Hepatology
2009;49:871–879.
[4] Hirschﬁeld GM, Liu X, Xu C, Lu Y, Xie G, Gu X, et al. Primary biliary cirrhosis
associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med
2009;360:2544–2555.
[5] Liu X, Invernizzi P, Lu Y, Kosoy R, Bianchi I, Podda M, et al. Genome-wide
meta-analyses identify three loci associated with primary biliary cirrhosis.
Nat Genet 2010;42:658–660.
[6] Mells GF, Floyd JA, Morley KI, Cordell HJ, Franklin CS, Shin SY, et al. Genome-
wide association study identiﬁes 12 new susceptibility loci for primary
biliary cirrhosis. Nat Genet 2011;43:329–332.2 vol. 56 j 731–733
JOURNAL OF HEPATOLOGY
[7] Yoshida K, Yang GX, Zhang W, Tsuda M, Tsuneyama K, Moritoki Y, et al.
Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dom-
inant negative transforming growth factor beta receptor type II mice.
Hepatology 2009;50:1494–1500.
[8] Trinchieri G. Interleukin-12 and the regulation of innate resistance and
adaptive immunity. Nat Rev Immunol 2003;3:133–146.
[9] Becher B, Durell BG, Noelle RJ. Experimental autoimmune encephalitis and
inﬂammation in the absence of interleukin-12. J Clin Invest
2002;110:493–497.Journal of Hepatology 201[10] Usui T, Preiss JC, Kanno Y, Yao ZJ, Bream JH, O’Shea JJ, et al. T-bet regulates
Th1 responses through essential effects on GATA-3 function rather than on
IFNG gene acetylation and transcription. J Exp Med 2006;203:755–766.
[11] Mantovani A, Locati M. Orchestration of macrophage polarization. Blood
2009;114:3135–3136.
[12] Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, et al.
IRF5 promotes inﬂammatory macrophage polarization and TH1-TH17
responses. Nat Immunol 2011;12:231–238.2 vol. 56 j 731–733 733
